Tri-Herbal Medicine Divya Sarva-Kalp-Kwath (Livogrit) Regulates Fatty Acid-Induced Steatosis in Human HepG2 Cells Through Inhibition of Intracellular Triglycerides and Extracellular Glycerol Levels

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2020 Oct 24

PMID 33096687

Citations 4

Authors

Acharya Balkrishna

Vivek Gohel

Rani Singh

Monali Joshi

Yash Varshney

Jyotish Srivastava

Kunal Bhattacharya

Anurag Varshney

Affiliations

Soon will be listed here.

Abstract

Steatosis is characterized by excessive triglycerides accumulation in liver cells. Recently, application of herbal formulations has gained importance in treating complex diseases. Therefore, this study explores the efficacy of tri-herbal medicine Divya Sarva-Kalp-Kwath (SKK; brand name, Livogrit) in treating free fatty acid (FFA)-induced steatosis in human liver (HepG2) cells and rat primary hepatocytes. Previously, we demonstrated that cytosafe SKK ameliorated CCl-induced hepatotoxicity. In this study, we evaluated the role of SKK in reducing FFA-induced cell-death, and steatosis in HepG2 through analysis of cell viability, intracellular lipid and triglyceride accumulation, extracellular free glycerol levels, and mRNA expression changes. Plant metabolic components fingerprinting in SKK was performed via High Performance Thin Layer Chromatography (HPTLC). Treatment with SKK significantly reduced the loss of cell viability induced by 2 mM-FFA in a dose-dependent manner. SKK also reduced intracellular lipid, triglyceride accumulation, secreted AST levels, and increased extracellular free glycerol presence in the FFA-exposed cells. SKK normalized the FFA-stimulated overexpression of SREBP1c, FAS, C/EBPα, and CPT1A genes associated with the induction of steatosis. In addition, treatment of rat primary hepatocytes with FFA and SKK concurrently, reduced intracellular lipid accumulation. Thus, SKK showed efficacy in reducing intracellular triglyceride accumulation and increasing extracellular glycerol release, along with downregulation of related key genetic factors for FFA-associated steatosis.

Citing Articles

Livogrit mitigates ANIT-induced cholestasis-like symptoms in an model by curbing hepatic inflammation and regulating BAX, TGF-β, MMP-9 and α-SMA gene expression.

Balkrishna A, Paliwal R, Singh S, Singh R, Gohel V, Dev R Heliyon. 2025; 11(3):e41855.

PMID: 39944325 PMC: 11815894. DOI: 10.1016/j.heliyon.2025.e41855.

Herbo-vitamin medicine Livogrit Vital ameliorates isoniazid induced liver injury (IILI) in human liver (HepG2) cells by decreasing isoniazid accumulation and oxidative stress driven hepatotoxicity.

Balkrishna A, Gohel V, Tomer M, Dev R, Varshney A BMC Complement Med Ther. 2024; 24(1):386.

PMID: 39516811 PMC: 11545855. DOI: 10.1186/s12906-024-04685-x.

Lowering -6/-3 Ratio as an Important Dietary Intervention to Prevent LPS-Inducible Dyslipidemia and Hepatic Abnormalities in Mice.

Park S, Lee J, Lee J, Lee J, Byun J, Kim I Int J Mol Sci. 2022; 23(12).

PMID: 35742829 PMC: 9224551. DOI: 10.3390/ijms23126384.

Livogrit, a herbal formulation of , and reverses the thioacetamide induced hepatocellular toxicity in zebrafish model.

Balkrishna A, Lochab S, Varshney A Toxicol Rep. 2022; 9:1056-1064.

PMID: 35571233 PMC: 9097504. DOI: 10.1016/j.toxrep.2022.03.053.

Livogrit Prevents Methionine-Cystine Deficiency Induced Nonalcoholic Steatohepatitis by Modulation of Steatosis and Oxidative Stress in Human Hepatocyte-Derived Spheroid and in Primary Rat Hepatocytes.

Balkrishna A, Gohel V, Kumari P, Manik M, Bhattacharya K, Dev R Bioengineered. 2022; 13(4):10811-10826.

PMID: 35485140 PMC: 9208489. DOI: 10.1080/21655979.2022.2065789.

References

Wang Y, Viscarra J, Kim S, Sul H . Transcriptional regulation of hepatic lipogenesis. Nat Rev Mol Cell Biol. 2015; 16(11):678-89. PMC: 4884795. DOI: 10.1038/nrm4074. View

Pagadala M, Kasumov T, McCullough A, Zein N, Kirwan J . Role of ceramides in nonalcoholic fatty liver disease. Trends Endocrinol Metab. 2012; 23(8):365-71. PMC: 3408814. DOI: 10.1016/j.tem.2012.04.005. View

Varshney R, Gupta S, Roy P . Cytoprotective effect of kaempferol against palmitic acid-induced pancreatic β-cell death through modulation of autophagy via AMPK/mTOR signaling pathway. Mol Cell Endocrinol. 2017; 448:1-20. DOI: 10.1016/j.mce.2017.02.033. View

Fontaine M, Dessein A, Douillard C, Dobbelaere D, Brivet M, Boutron A . A Novel Mutation in CPT1A Resulting in Hepatic CPT Deficiency. JIMD Rep. 2013; 6:7-14. PMC: 3565650. DOI: 10.1007/8904_2011_94. View

Balkrishna A, Ranjan R, Sakat S, Sharma V, Shukla R, Joshi K . Evaluation of polyherbal ayurvedic formulation 'Peedantak Vati' for anti-inflammatory and analgesic properties. J Ethnopharmacol. 2019; 235:361-374. DOI: 10.1016/j.jep.2019.01.028. View

Swagell C, Henly D, Morris C . Expression analysis of a human hepatic cell line in response to palmitate. Biochem Biophys Res Commun. 2005; 328(2):432-41. DOI: 10.1016/j.bbrc.2004.12.188. View

Perumpail B, Khan M, Yoo E, Cholankeril G, Kim D, Ahmed A . Clinical epidemiology and disease burden of nonalcoholic fatty liver disease. World J Gastroenterol. 2018; 23(47):8263-8276. PMC: 5743497. DOI: 10.3748/wjg.v23.i47.8263. View

Joshi-Barve S, Barve S, Amancherla K, Gobejishvili L, Hill D, Cave M . Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes. Hepatology. 2007; 46(3):823-30. DOI: 10.1002/hep.21752. View

Tang Y, Bian Z, Zhao L, Liu Y, Liang S, Wang Q . Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease. Clin Exp Immunol. 2011; 166(2):281-90. PMC: 3219903. DOI: 10.1111/j.1365-2249.2011.04471.x. View

10.

Balkrishna A, Sakat S, Joshi K, Joshi K, Sharma V, Ranjan R . Cytokines Driven Anti-Inflammatory and Anti-Psoriasis Like Efficacies of Nutraceutical Sea Buckthorn () Oil. Front Pharmacol. 2019; 10:1186. PMC: 6797847. DOI: 10.3389/fphar.2019.01186. View

11.

Mishra S, Aeri V, Gaur P, Jachak S . Phytochemical, therapeutic, and ethnopharmacological overview for a traditionally important herb: Boerhavia diffusa Linn. Biomed Res Int. 2014; 2014:808302. PMC: 4053255. DOI: 10.1155/2014/808302. View

12.

Pan Z, Wang J, Tang H, Li L, Lv J, Xia L . Effects of palmitic acid on lipid metabolism homeostasis and apoptosis in goose primary hepatocytes. Mol Cell Biochem. 2010; 350(1-2):39-46. DOI: 10.1007/s11010-010-0680-6. View

13.

Niklas J, Bonin A, Mangin S, Bucher J, Kopacz S, Matz-Soja M . Central energy metabolism remains robust in acute steatotic hepatocytes challenged by a high free fatty acid load. BMB Rep. 2012; 45(7):396-401. DOI: 10.5483/bmbrep.2012.45.7.070. View

14.

Chang J, Chung D, Lee Y, Wen B, Jao H, Wang C . Solanum nigrum Polyphenol Extracts Inhibit Hepatic Inflammation, Oxidative Stress, and Lipogenesis in High-Fat-Diet-Treated Mice. J Agric Food Chem. 2017; 65(42):9255-9265. DOI: 10.1021/acs.jafc.7b03578. View

15.

Asrani S, Devarbhavi H, Eaton J, Kamath P . Burden of liver diseases in the world. J Hepatol. 2018; 70(1):151-171. DOI: 10.1016/j.jhep.2018.09.014. View

16.

Lin C, Peng Y, Lin Y, Mersmann H, Ding S . LRRK2 Regulates CPT1A to Promote β-Oxidation in HepG2 Cells. Molecules. 2020; 25(18). PMC: 7570678. DOI: 10.3390/molecules25184122. View

17.

Gomez-Lechon M, Donato M, Martinez-Romero A, Jimenez N, Castell J, OConnor J . A human hepatocellular in vitro model to investigate steatosis. Chem Biol Interact. 2006; 165(2):106-16. DOI: 10.1016/j.cbi.2006.11.004. View

18.

Park S, Choi Y, Um S, Yoon S, Park T . Oleuropein attenuates hepatic steatosis induced by high-fat diet in mice. J Hepatol. 2010; 54(5):984-93. DOI: 10.1016/j.jhep.2010.08.019. View

19.

Mokdad A, Forouzanfar M, Daoud F, Mokdad A, El Bcheraoui C, Moradi-Lakeh M . Global burden of diseases, injuries, and risk factors for young people's health during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2016; 387(10036):2383-401. DOI: 10.1016/S0140-6736(16)00648-6. View

20.

Han Y, Hu Z, Cui A, Liu Z, Ma F, Xue Y . Post-translational regulation of lipogenesis via AMPK-dependent phosphorylation of insulin-induced gene. Nat Commun. 2019; 10(1):623. PMC: 6367348. DOI: 10.1038/s41467-019-08585-4. View